• FirefoxUpgrade to the new Firefox »
  •  Dow Up2.43% Nasdaq Up2.24%

    Ariad Pharmaceuticals Inc. (ARIA)

    -NasdaqGS
    6.61 0.25(3.93%) Dec 18, 4:00PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 45,561   558   25,300  
    Cost of Revenue9,612   -   -  
    Gross Profit 35,949   558   25,300  
    Operating Expenses
    Research Development162,900  144,709  77,743  
    Selling General and Administrative146,615  60,909  24,380  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (273,566) (205,060) (76,823)
    Income from Continuing Operations
    Total Other Income/Expenses Net -  (15,613)(46,548)
    Earnings Before Interest And Taxes(273,566)(220,673)(123,371)
    Interest Expense153  199  232  
    Income Before Tax(273,719)(220,872)(123,603)
    Income Tax Expense439   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(274,158)(220,872)(123,603)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (274,158) (220,872) (123,603)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (274,158) (220,872) (123,603)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.